Neylan John F. 4
4 · Angion Biomedica Corp. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Neylan John F.
See Remarks
Transactions
- Sale
Common Stock
[F1]2021-06-18$13.20/sh−366$4,831→ 37,363 total
Footnotes (1)
- [F1]The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for John F. Neylan|2021-06-21